Skip to main content
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DALINGO 82.5 mg PROLONGED-RELEASE TABLETS

Contents of the leaflet

  1. Introduction
  2. What Dalingo is and what it is used for
  3. What you need to know before you take Dalingo
  4. How to take Dalingo
  5. Possible Adverse Effects
  6. Storage of Dalingo
  7. Package Contents and Additional Information

Introduction

Package Leaflet: Information for the User

Dalingo 82.5mg prolonged-release tablets

Dalingo 165mg prolonged-release tablets

Dalingo 330mg prolonged-release tablets

pregabalin

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Dalingo is and what it is used for
  2. What you need to know before you take Dalingo
  3. How to take Dalingo
  4. Possible side effects
  5. Storage of Dalingo
  6. Contents of the pack and other information

1. What Dalingo is and what it is used for

Dalingo belongs to a group of medicines used to treat neuropathic pain in adults.

Pregabalin is used to treat long-term pain caused by damage to the nerves. There are several diseases that can cause peripheral neuropathic pain, such as diabetes or herpes. The feeling of pain can be described as heat, burning, throbbing, stabbing, sharp, crampy, aching, tingling, numbness, and a feeling of pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can have an impact on physical and social activity and overall quality of life.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Dalingo

Do not take Dalingo

If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking this medicine.

  • Some patients taking pregabalin have reported symptoms that suggest an allergic reaction. These symptoms include swelling of the face, lips, tongue, and throat, as well as the appearance of a diffuse rash. If you experience any of these symptoms, you should see your doctor immediately.
  • Severe skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with pregabalin treatment. Stop taking pregabalin and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
  • Pregabalin, the active substance in this medicine, has been associated with dizziness and somnolence, which could increase the risk of accidental injury (falls) in elderly patients. Therefore, you should be cautious until you are used to the effects of the medicine.
  • This medicine may cause blurred vision, loss of vision, or other changes in vision, many of which are transient. If you experience any changes in your vision, you should inform your doctor immediately.
  • Diabetic patients who gain weight while taking pregabalin may need a change in their diabetes medications.
  • Certain side effects, such as somnolence, may be more frequent because patients with spinal cord injury may be taking other medications for treatment, such as pain or spasticity, with similar side effects to pregabalin, so the intensity of these effects may increase when taken together.
  • There have been reports of heart failure in some patients treated with pregabalin. Most of them were elderly patients with cardiovascular disease. Before using this medicine, you should tell your doctor if you have a history of heart disease.
  • There have been reports of renal failure in some patients treated with pregabalin. If, during treatment with this medicine, you notice a decrease in your ability to urinate, you should inform your doctor, as stopping treatment may improve this situation.
  • Some patients taking antiepileptics, such as pregabalin, have had thoughts of harming themselves or committing suicide or have shown suicidal behavior. If at any time you have these thoughts or have shown such behavior, contact your doctor as soon as possible.
  • When this medicine is taken with other medicines that can cause constipation (such as some types of pain medications), gastrointestinal problems (such as constipation and intestinal blockage or paralysis) may occur. Inform your doctor if you suffer from constipation, especially if you are prone to this problem.
  • Before taking this medicine, inform your doctor if you have ever abused or been dependent on alcohol, prescription medications, or illegal drugs; this may mean you have a higher risk of becoming dependent on this medicine.
  • There have been reports of seizures during treatment with pregabalin or shortly after stopping treatment. If you experience seizures, contact your doctor immediately.
  • There have been reports of reduced brain function (encephalopathy) in some patients taking pregabalin who had other illnesses. Tell your doctor if you have a history of any serious illness, including liver or kidney disease.
  • There have been reports of difficulty breathing. If you have nervous system disorders, respiratory disorders, kidney failure, or are over 65 years old, your doctor may prescribe a different dose. Contact your doctor if you experience breathing problems or shallow breathing.

Dependence

Some people may become dependent on pregabalin (need to continue taking the medicine). These people may experience withdrawal effects when they stop using this medicine (see section 3, "How to take Dalingo" and "If you stop taking Dalingo"). If you are concerned that you may become dependent on this medicine, it is important that you consult your doctor.

If you notice any of the following signs while taking pregabalin, it could be a sign that you have become dependent:

  • You need to take the medicine for a longer period than recommended by your doctor.
  • You feel that you need to take more than the recommended dose.
  • You are using the medicine for reasons other than those prescribed.
  • You have made repeated unsuccessful attempts to stop or control the use of the medicine.
  • When you stop taking the medicine, you feel unwell and feel better once you take the medicine again.

If you notice any of these signs, talk to your doctor to discuss the best care plan for you, including when it is appropriate to stop treatment and how to do it safely.

Children and adolescents

The safety and efficacy in children and adolescents (under 18 years) have not been established, so pregabalin should not be used in this age group.

Other medicines and Dalingo

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Pregabalin and certain medicines may interact with each other (interactions). When pregabalin is used with certain sedating medicines (including opioids), these effects may be increased, and may lead to respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if pregabalin is taken with other medicines that contain:

  • Oxycodone (used as a pain reliever)
  • Lorazepam (used to treat anxiety)
  • Alcohol

Pregabalin can be taken with oral contraceptives.

Taking Dalingo with food, drinks, and alcohol

It is advised not to drink alcohol during treatment with this medicine. For more information on treatment with pregabalin in relation to food, see section3, "How to take Dalingo".

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Do not take this medicine during pregnancy or breastfeeding, unless your doctor has told you to. The use of pregabalin during the first 3 months of pregnancy may cause congenital malformations in the fetus that require medical treatment. In a study that reviewed data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 babies out of 100 had such congenital malformations. This compares with 4 babies out of 100 born to women not treated with pregabalin in the study. There have been reports of malformations of the face (orofacial clefts), eyes, nervous system (including the brain), kidneys, and genitals.

Women of childbearing age should use effective contraception.

Driving and using machines

Pregabalin may cause dizziness, somnolence, and decreased concentration. You should not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.

3. How to take Dalingo

Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.

Pregabalin is for oral use only. You should take pregabalin once a day, in the evening, immediately after dinner. Swallow the tablet whole with water. Do not break, crush, or chew the tablet. The tablet should not be broken because this could affect its properties.

Your doctor will determine the dose that is right for you.

  • Take the number of tablets that your doctor has told you to.
  • The usual dose, which will have been adjusted for you and your condition, is between 165 mg and 660 mg per day.

If you think that the effect of pregabalin is too strong or too weak, talk to your doctor or pharmacist.

If you are an elderly patient (over 65 years of age), you should take this medicine normally, unless you have kidney problems.

Your doctor may prescribe a different dosing regimen and/or different doses if you have kidney problems.

Continue taking pregabalin until your doctor tells you to stop.

Switching from immediate-release pregabalin to prolonged-release pregabalin, such as this medicine:

When switching from immediate-release pregabalin to prolonged-release pregabalin, such as this medicine, your doctor will explain how to do it. He/she will tell you to follow these steps:

  • take your dose of immediate-release pregabalin in the morning as prescribed
  • then start taking pregabalin after dinner

Do not switch medicines unless your doctor has told you to. He/she will also tell you the right dose for your condition.

If you have any questions or doubts, ask your doctor.

If you take more Dalingo than you should

Call your doctor or go to the nearest emergency room immediately. Take the pack or container (bottle) of pregabalin tablets with you. As a result of taking more pregabalin than you should, you may feel drowsy, confused, agitated, or restless. There have also been reports of seizures and loss of consciousness (coma).

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.

If you forget to take Dalingo

It is important that you take the pregabalin tablets regularly at the same time each day. If you forget to take a dose, take it as soon as you remember, always after eating, unless it is time for the next dose. In that case, continue with the next dose as usual. Do not take a double dose to make up for forgotten doses.

If you stop taking Dalingo

Do not stop taking pregabalin suddenly. If you want to stop taking pregabalin, talk to your doctor first. Your doctor will tell you how to do it. If you are going to stop treatment, it should be done gradually over a minimum of one week. Once you have finished short-term or long-term treatment with pregabalin, you should be aware that you may experience certain side effects, called withdrawal effects. These effects include sleep problems, headache, nausea, feeling anxious, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of harming yourself or committing suicide, pain, sweating, and dizziness. These effects may occur more frequently or severely if you have been taking pregabalin for a longer period. If you experience withdrawal effects, you should see your doctor.

If you have any doubts about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

Very Common: may affect more than 1 in 10 people

Dizziness, drowsiness, headache.

Common: may affect up to 1 in 10 people

  • Increased appetite.
  • Feeling of euphoria, confusion, disorientation, decreased sexual appetite, irritability.
  • Attention alteration, movement clumsiness, memory impairment, memory loss, tremors, difficulty speaking, tingling sensation, numbness, sedation, lethargy, insomnia, fatigue, abnormal sensation.
  • Blurred vision, double vision.
  • Dizziness, balance problems, falls.
  • Dry mouth, constipation, vomiting, flatulence, diarrhea, nausea, bloated abdomen.
  • Difficulty getting an erection.
  • Body swelling including limbs.
  • Feeling of drunkenness, gait disturbances.
  • Weight gain
  • Muscle cramp, joint pain, back pain, limb pain.
  • Sore throat.

Uncommon: may affect up to 1 in 100 people

  • Loss of appetite, weight loss, low blood sugar levels, high blood sugar levels.
  • Change in self-perception, restlessness, depression, agitation, mood changes, difficulty finding words, hallucinations, strange dreams, anxiety attacks, apathy, aggression, elevated mood, mental deterioration, difficulty thinking, increased sexual appetite, sexual relationship problems including inability to reach climax, delayed ejaculation.
  • Changes in vision, unusual eye movements, changes in vision including tunnel vision, flashes of light, spasmodic movements, reduced reflexes, hyperactivity, dizziness when standing up, sensitive skin, loss of taste, burning sensation, tremor when moving, decreased consciousness, loss of consciousness, fainting, increased sensitivity to noise, general malaise.
  • Dry eyes, eye swelling, eye pain, tired eyes, teary eyes, eye irritation.
  • Heart rhythm disturbances, increased heart rate, low blood pressure, high blood pressure, changes in heart rhythm, heart failure.
  • Flushing, hot flashes.
  • Breathing difficulties, dry nose, nasal congestion.
  • Increased saliva production, heartburn, numbness around the mouth.
  • Sweating, rash, chills, fever.
  • Muscle spasms, joint swelling, muscle stiffness, pain including muscle pain, neck pain.
  • Breast pain.
  • Difficulty or pain when urinating, inability to hold urine.
  • Weakness, thirst, chest tightness.
  • Changes in blood and liver test results (elevated creatine phosphokinase in blood, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased platelet count, neutropenia, increased creatinine in blood, decreased potassium in blood).
  • Hypersensitivity, facial swelling, itching, urticaria, runny nose, nosebleeds, cough, snoring.
  • Painful menstrual periods.
  • Cold sensation in hands and feet.

Rare: may affect up to 1 in 1,000 people

  • Altered sense of smell, oscillating vision, depth perception alteration, visual glare, loss of vision.
  • Dilated pupils, strabismus.
  • Cold sweat, throat tightness, tongue swelling.
  • Pancreatitis.
  • Difficulty swallowing.
  • Slow or reduced body mobility.
  • Difficulty writing correctly.
  • Increased fluid in the abdominal area.
  • Fluid in the lungs.
  • Seizures.
  • Changes in the electrocardiogram (ECG) corresponding to heart rhythm disturbances.
  • Muscle damage.
  • Milk secretion, abnormal breast growth, increased breast size in men.
  • Menstrual period interruption.
  • Kidney failure, reduced urine output, urine retention.
  • Decreased white blood cell count.
  • Inappropriate behavior, suicidal behavior, suicidal thoughts.
  • Allergic reactions that may include difficulty breathing, eye inflammation (keratitis) and a severe skin reaction characterized by reddish, non-raised, circular or coin-shaped patches on the chest, often with central blisters, skin peeling, ulcers in the mouth, throat, nose, genitals, and eyes. These severe skin reactions can be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis).
  • Jaundice (yellow skin and eyes).
  • Parkinsonism, symptoms similar to Parkinson's disease, such as tremors, bradykinesia (decreased ability to move) and muscle stiffness.

Very Rare: may affect up to 1 in 10,000 people

  • Liver failure.
  • Hepatitis (liver inflammation).

Frequency Not Known: cannot be estimated from the available data

  • Becoming dependent on pregabalin ('drug dependence').

Once you have finished a short or long-term treatment with this medicine, you should know that you may experience certain adverse effects, called withdrawal effects (see "If you stop treatment with Dalingo").

If you experience swelling in the face or tongue, or if your skin turns red and has blisters or peeling, you should seek medical attention immediately.

Certain adverse effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medicines to treat, for example, pain or spasticity, with similar adverse effects to those of pregabalin, so the intensity of these effects may increase when these medicines are taken together.

The following adverse reaction has been reported in post-marketing experience: difficulty breathing, shallow breathing.

Reporting of Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Dalingo

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date that appears on the box or packaging (bottle). The expiration date is the last day of the month indicated.

For 82.5 mg:Do not store above 30 °C.

For 165 mg and 330 mg:This medicine does not require special storage conditions

Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.

6. Package Contents and Additional Information

Composition of Dalingo

The active ingredient is pregabalin.

Dalingo 82.5 mg prolonged-release tablets

Each prolonged-release tablet contains 82.5 mg of pregabalin.

Dalingo 165 mg prolonged-release tablets

Each prolonged-release tablet contains 165 mg of pregabalin.

Dalingo 330 mg prolonged-release tablets

Each prolonged-release tablet contains 330 mg of pregabalin.

The other components are:

  • Tablet content: hypromellose, hydroxypropylcellulose (E 463), basic butyl methacrylate copolymer (E 1205), crospovidone (type A), magnesium stearate (E 470b), anhydrous colloidal silica (E 551).
  • Coating material: poly (vinyl alcohol) (E 1203), titanium dioxide (E 171), macrogol (E 1521), and talc (E 553b).

Dalingo 165 mg prolonged-release tablets

also contain yellow iron oxide (E 172) and red iron oxide (E 172).

Dalingo 330 mg prolonged-release tablets

also contain red iron oxide (E 172) and black iron oxide (E 172).

  • Printing ink: shellac, black iron oxide (E 172), propylene glycol (E 1520)

Product Appearance and Package Contents

Dalingo 82.5 mg prolonged-release tablets

White, oval, uncoated tablet, without inscription on one side and with the inscription "ALV 379" printed in black ink on the other side, with 19 mm length, 12 mm width, and approximately 7 mm thickness.

Dalingo 165 mg prolonged-release tablets

Yellow, oval, uncoated tablet, without inscription on one side and with the inscription "ALV 380" printed in black ink on the other side, with 19 mm length, 12 mm width, and approximately 7 mm thickness.

Dalingo 330 mg prolonged-release tablets

Pink, oval, uncoated tablet, without inscription on one side and with the inscription "ALV 381" printed in black ink on the other side, with 19 mm length, 12 mm width, and approximately 8 mm thickness.

Dalingo is available in:

  • Cardboard box containing a round, white, wide-mouthed HDPE bottle with a child-resistant closure and a desiccant cylinder.
  • Original packaging with 30 prolonged-release tablets.

Multipack packaging with 90 (3 x 30) prolonged-release tablets.

Only certain pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Laboratorios Gebro Pharma S.A.

Avenida Tibidao, 29

08022 Barcelona

Spain

Manufacturer:

Kevaro Group Ltd

9 Tzaritza Elenora Str., Office 23

Sofia, 1618

Bulgaria

This medicine is authorized in the Member States of the European Economic Area with the following names:

Spain – Dalingo 82.5 mg prolonged-release tablets

Dalingo 165 mg prolonged-release tablets

Dalingo 330 mg prolonged-release tablets

Netherlands – Dalingo 82.5 mg tabletten met verlengde afgifte

Dalingo 165 mg tabletten met verlengde afgifte

Dalingo 330 mg tabletten met verlengde afgifte

Date of the last revision of this prospectus: September 2024

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for DALINGO 82.5 mg PROLONGED-RELEASE TABLETS

Discuss questions about DALINGO 82.5 mg PROLONGED-RELEASE TABLETS, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor

Chikeluo Okeke

General medicine4 years of experience

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Book a video appointment
€66
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

DALINGO 82.5 mg PROLONGED-RELEASE TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in DALINGO 82.5 mg PROLONGED-RELEASE TABLETS is pregabalin. This information helps identify medicines with the same composition but different brand names.

The average pharmacy price for DALINGO 82.5 mg PROLONGED-RELEASE TABLETS is around 8.66 EUR. Prices may vary depending on the manufacturer and dosage form.

DALINGO 82.5 mg PROLONGED-RELEASE TABLETS is manufactured by Laboratorios Gebro Pharma S.A.. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Psychiatrists, Neurologists, General medicine doctors, Pain medicine doctors, Anaesthesiologists may assess whether DALINGO 82.5 mg PROLONGED-RELEASE TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, DALINGO 82.5 mg PROLONGED-RELEASE TABLETS is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (pregabalin) include ACIRYL 150 mg HARD CAPSULES, ACIRYL 25 mg HARD CAPSULES, ACIRYL 300 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media